title: [The Use of Fixed Perindopril A/Amlodipine Combination Provides High Compliance to Therapy, Effective and Safe Arterial Pressure Lowering in Patients With Previous Inefferctive Therapy. The POTENTIAL Program].
abstract: Aim of the postmarketing obsevational program POTENTIAL () was to assess in real clinical practice efficacy and safety of therapy with fixed perindopril A/amlodipine combination (FP/AC) in patients with artrial hypertension uncontrolled by preceeding therapy.
  
  
  
  Included patients (n=1351, 527 men [39%], 824 women [61%] were observed by 243 physicians.
authors.affiliation: Sechenovs First Moscow Medical State University, Moscow, Russia.
authors.forename: M G
authors.initials: MG
authors.lastname: Glezer On Behalf Of Program Participants
mesh_terms: D017311:Amlodipine / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D062186:Arterial Pressure / Q000187:drug effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D020913:Perindopril / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; C542336:amlodipine, perindopril drug combination; D017311:Amlodipine; D020913:Perindopril